Direct and Indirect Effects of COVID-19 in Frail Elderly: Interventions and Recommendations.
María Guadalupe Pizano-EscalanteLuis Miguel Anaya-EsparzaKarla NuñoJosé de Jesús Rodríguez-RomeroYesica Sughey Gonzalez-TorresDavid A López-de la MoraZuamí Villagrán-de la MoraPublished in: Journal of personalized medicine (2021)
Frailty is a state of vulnerability to stressors because of a decreased physiological reserve, resulting in poor health outcomes. This state is related to chronic conditions, many of which are risk factors for outcomes in elderly patients having SARS-COV-2. This review aims to describe frailty as a physiological vulnerability agent during the COVID-19 pandemic in elderly patients, summarizing the direct and indirect effects caused by the SARS-COV-2 infection and its prognosis in frail individuals, as well as the interventions and recommendations to reduce their effects. Cohort studies have shown that patients with a Clinical Frailty Scale higher than five have a higher risk of mortality and use of mechanical ventilation after COVID-19; nonetheless, other scales have also associated frailty with longer hospital stays and more severe forms of the disease. Additionally, the indirect effects caused by the pandemic have a negative impact on the health status of older people. Due to the above, a holistic intervention is proposed based on a comprehensive geriatric assessment for frail patients (preventive or post-infection) with emphasis on physical activity and nutritional recommendations, which could be a potential preventive intervention in viral infections by COVID-19.
Keyphrases
- sars cov
- community dwelling
- coronavirus disease
- physical activity
- respiratory syndrome coronavirus
- mechanical ventilation
- randomized controlled trial
- end stage renal disease
- intensive care unit
- climate change
- clinical practice
- risk factors
- newly diagnosed
- cardiovascular disease
- type diabetes
- ejection fraction
- chronic kidney disease
- peritoneal dialysis
- respiratory failure
- acute care
- middle aged
- adverse drug